Silke Retlich
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Peptidase Inhibition and Analysis
Papers in
-
- Diabetes Treatment and Management 15
- Diabetes Management and Research 3
- Co-authors
- Ulrike Graefe‐ModyChristian FriedrichArne RingAlexander StaabUlrich JaehdeAndreas PortAtef HalabiH.J. Woerle
- Journals
- Clinical Pharmacokinetics (3 papers)Diabetes Obesity and Metabolism (2 papers)British Journal of Clinical Pharmacology (2 papers)Expert Opinion on Investigational Drugs (2 papers)BMJ Open (1 paper)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Silke Retlich
17 papers receiving 544 citations
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 460
- Oncology 189
- Cellular and Molecular Neuroscience 96
- Pharmacology 67
- Surgery 155
Countries citing papers authored by Silke Retlich
This map shows the geographic impact of Silke Retlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Retlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Retlich more than expected).
Fields of papers citing papers by Silke Retlich
This network shows the impact of papers produced by Silke Retlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Retlich. The network helps show where Silke Retlich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Silke Retlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2017 | 16 | |
| 5 | 2016 | 18 | |
| 6 | 2015 | 14 | |
| 7 | 2015 | 8 | |
| 8 | 2013 | 29 | |
| 9 | 2013 | 11 | |
| 10 | 2013 | 13 | |
| 11 | 2013 | 3 | |
| 12 | 2012 | 2 | |
| 13 | 2012 | 62 | |
| 14 | 2012 | 109 | |
| 15 | 2011 | 148 | |
| 16 | 2010 | 43 | |
| 17 | 2010 | 45 | |
| 18 | 2009 | 43 |
About Silke Retlich
Silke Retlich is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Nephrology, Oncology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 567 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (15 papers), Peptidase Inhibition and Analysis (7 papers), Neuropeptides and Animal Physiology (6 papers), Diabetes Management and Research (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (460 citations), Oncology (189 citations), Cellular and Molecular Neuroscience (96 citations), Pharmacology (67 citations) and Surgery (155 citations). Silke Retlich has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Ulrike Graefe‐Mody, Christian Friedrich, Arne Ring, Alexander Staab, Ulrich Jaehde, Andreas Port, Atef Halabi, H.J. Woerle, Tim Heise and Vincent Duval. Their work appears in journals such as Clinical Pharmacokinetics, Diabetes Obesity and Metabolism, British Journal of Clinical Pharmacology, Expert Opinion on Investigational Drugs and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.